bevacizumab
roche
['cairo5', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm']
phiii cairo5 #1l unresectable #crlm shows folfoxiri-bev improves pfs, orr, r0/r1 resection +/- ablation rates vs folfox/folfiri-bev in pts w/#mcrc having right-sided and/or ras/brafv600e mutated primary tumors; os not mature #asco22 #crcsm 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope